| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
2; author reply 782 |
| issn |
0098-7484 |
| issueIdentifier |
8 |
| pageRange |
781-2; author reply 782 |
| publicationName |
JAMA |
| startingPage |
781 |
| bibliographicCitation |
Holtzman NA, Starfield B. Withdrawing FDA approval of midodrine after marketing. JAMA. 2011 Feb 23;305(8):781–2; author reply 782. doi: 10.1001/jama.2011.161. PMID: 21343575. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb035d5b748a89395cc1fb65e1e6c6e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4c1200354b6671e30ccdd8c17328397 |
| date |
2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1001/jama.2011.161
https://pubmed.ncbi.nlm.nih.gov/21343575 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0098-7484
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5346 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Withdrawing FDA Approval of Midodrine After Marketing |
| discusses |
http://id.nlm.nih.gov/mesh/M0543920
http://id.nlm.nih.gov/mesh/M0013860 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D056737
http://id.nlm.nih.gov/mesh/D008879Q000009
http://id.nlm.nih.gov/mesh/D058646Q000009
http://id.nlm.nih.gov/mesh/D011358Q000592 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D030881
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D004345
http://id.nlm.nih.gov/mesh/D002986 |